Clinical Trials Directory

Trials / Completed

CompletedNCT02344758

Gluten-free Diet Monitoring in Urine

Non-invasive Gluten-free Diet Adherence Monitoring in Celiac Patients: Detection of Gluten Immunogenic Peptides in Urine

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
134 (actual)
Sponsor
University of Seville · Academic / Other
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develope a novel method to determine gluten intake and to check gluten-free diet adherence in celiac patients by detection of gluten immunogenic peptides in urine.

Detailed description

To date, the mainstay of the management of CD is a strict life-long adherence to gluten-free diet (GFD). Follow-up monitoring of the improvement of patients on GFD is essential to assess symptomatic recovery and to monitor complications, as well as to assist patients with dietary compliance. However, practical methods to monitor diet compliance and to detect the origin of an outbreak of celiac clinical symptoms are not available. In this study, we have overcome these challenges and shown the feasibility of measuring gluten immunogenic peptides (GIP) in urine samples in healthy and celiac individuals by solid phase extraction and estimating the peptide concentrations with a reader of anti-GIP moAb immunochromatographic strips (IC-strips).

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive lateral flow test for monitoring gluten intake
BEHAVIORALgluten-free diet (GFD)
BEHAVIORALgluten-containing diet

Timeline

Start date
2013-04-01
Primary completion
2013-07-01
Completion
2013-12-01
First posted
2015-01-26
Last updated
2015-01-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02344758. Inclusion in this directory is not an endorsement.